Animalcare Group PLC (ANCR)

Industry Drug Manufacturers - Specialty & Generic


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

330.00p

Buy

333.00p

arrow-up0.00p (+0.00%)

Prices updated at 17 Jun 2026, 17:15 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised ...
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Edwin Thomas William Torr
CEO
Ms. Jennifer Ann Julia Winter
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
220
Head office
Monks Cross Drive
York
United Kingdom
YO32 9LB
mobile
+44 1904487687
letter
Investors@animalcare.co.uk

Key personnel

Salary
Mr. Edwin Thomas William Torr
Non-Executive Director, Chairman
-
Dr. Douglas Eugene Hutchens
Non-Executive Director
-
Mr. Christopher Brewster
Executive Director, Chief Financial Officer and Company Secretary
-
Ms. Jennifer Ann Julia Winter
Executive Director, Chief Executive Officer
-

Top 5 shareholders

No. of shares
Liontrust Investment Partners LLP3,786,556
Liontrust UK Smaller Companies Fund3,470,522
Hargreave Hale Limited1,973,597
Unicorn Asset Management Ltd1,656,900
Unicorn AIM VCT Series 3 ORD1,656,900

Director dealings

Action
19 Nov 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.